The FcyR receptors for IgG, FcyRI, FcyRII and FcyRIII were measured on neutrophils and monocytes from 36 patients suspected of systemic infection. These results were compared with 30 blood donor controls to assess the level of expression as an early indicator of bacterial infection. FcyRI expression on neutrophils was found to be significantly increased from patients with systemic or localised infections, when compared to the non-infected patient group, i.e., patients with no cultural evidence of bacterial infections, (p = 0.02, p = 0.04) or normal controls (p C 0.0001, p = 0.0005). FcyRI expression on monocytes was also significantly increased in both of the infected groups compared to normal controls (p < 0.0001, p = 0.001); however, no significant difference could be seen when compared with the non-infected patients. Fc yRIII was found to be significantly increased on a subset of monocytes in patients with systemic or localised infections compared to the non-infected group (p = 0.009, p = 0.006) and compared to the normal controls (p = 0.009, p = 0.003). Infections caused by gramnegative bacilli induced a higher FcyR response than infection with either streptococci or staphylococci. These data suggest that the measurement of FcyRI on neutrophils and FcyRIII on monocytes may be a useful rapid indicator of bacterial infection.
Introduction
Despite appropriate antimicrobial chemotherapy, one of the most frequent and serious problems facing clinicians is the management of patients with severe infection [l, 21. Prompt diagnosis is essential to improve prognosis. The development of methods for the early detection of infection based on the measurement of host immune response, rather than sometimes lengthy culture techniques, would be advantageous.
Human phagocytes express three distinct classes of receptors for the Fc domain of IgG designated FcyRI (CD64), FcyRII (CD32) and FcyRIII (CD16) [3, 4] . In the body, these receptors form a two-way bridge between the humoral response and the cellular branch of the immune system [5] . When Fcy receptors (Fc yR) interact with immunoglobulin, various important biological responses are triggered, such as phagocytosis, endocytosis, antibody-dependent cellular cytotoxicity, release of inflammatory mediators and enhancement of antigen presentation [6]. Therefore, it is expected that as these receptors and their regulation have a priority in infection, the cellular immune response to bacterial challenge would involve in-creased expression of FcyR on the phagocytic cells, at an early stage of infection.
Early studies have already indicated that FcyRI expression is increased in acute bacterial infection [7] . Other studies have shown that IFN-y can bring about a dramatic increase in FcyRI expression on both monocytes [8] and neutrophils [9] . More recent work has also shown that FcyRI expression is increased on neutrophils and augmented on monocytes in patients with localised P-haemolytic streptococcal (potent IFN-y inducers) pharyngitis [lo] . This study was designed to investigate whether Fc yR expression is also increased in systemic infection and, if so, whether its measurement could be used as an early indicator of infection.
Materials and methods

Patient population
Whole blood EDTA samples were collected from 36 patients with suspected systemic infection, at the time of blood culture analysis. Thirty EDTA samples were also collected from blood donors as healthy controls. Of the 36 patients tested, 16 had systemic infection, i.e., clinically significant bacteria were isolated from the blood culture. These isolates consisted of the following: Staphylococcus aureus (n = 5 , four of which were methicillin-and gentamicin-resistant strains); Streptococcus pneumoniae (n = 2), Enterococcus sp. (n = l), Escherichia coli (n = 5), Enterobacter cloacae (n= l), Klebsiella oxytoca (n= 1) and Pseudomonas putida (n = 1). Six patients were blood-culture negative but had severe localised bacterial infections at other sites. Of these patients, four had infections in the lower respiratory tract caused by gram-negative pathogens such as K. pneumoniae, R aeruginosa, E. coli and Haemophilus injluenzae. Another of these patients had peritonitis due to E. coli whilst the remaining patient had Clostridium dijjficile-associated diarrhoea. The remaining 14 patients tested had no cultural evidence of bacterial infection. Viral studies were not performed on the patients tested.
Fluorescent staining
FcyR expression was detected by a direct staining immunofluorescence technique with fluorescein isothiocyanate (F1TC)-labelled monoclonal antibodies (MAbs) against FcyRI (CD64), FcyRII (CD32) and FcyRIII (CD 16) (Medarex, Princeton, NJ, USA). Phycoerythrin (PE)-labelled CD 14 (BD) was used as a monocytic marker. A non-sense antibody, y1y2, (BD) was also used as a control for non-specific binding. The receptors were stained by a whole blood lysis technique on a single EDTA specimen which was divided into four 100-pl volumes. Five pl of the three FcyR antibodies were added to three of the tubes, respectively. Non-sense antibody (5 pl) was added to the fourth tube. A further 5 pl of the CD14 antibody was added to each tube. After incubation for 10 min at room temperature, 2 ml of red cell lysis solution (BD) were added to each tube and tubes were incubated for a further 10 min. Tubes were centrifbged at 5000 rpm for 5 min after which the supernate was discarded. Samples were then washed in FACS flow fluid (BD), and fixed in paraformaldehyde 1% in PBS.
Flow cytometric analysis
Flow cytometric measurement of the stained samples was performed with a single laser (Argon ion 488 nm) FACSCAN flow cytometer (BD). CaliBRITE beads (BD) were used daily to set the PMT voltages and the fluorescent compensation and also as a check on instrument sensitivity. Patient samples were acquired at a rate of c. 200 cellsh, such that 10 000 events were counted on each sample. LYSIS software was then used to estimate MAb binding on the neutrophils and the monocytes. Neutrophils were distinguished and electronically gated on the basis of their size and granularity, by means of a dot plot of forward scatter (FSC) versus side scatter (SSC). Gating on the PE-labelled monocytes was performed with a dot plot of the fluorescent intensity of FITC (FL1) versus the fluorescence intensity of PE (FL2). The mean fluorescence intensity (MFI) of each of the cell populations was then calculated from a profile histogram of the FL1 for each sample. For FcyRIII, which is expressed only on a subpopulation of monocytes, the percentage of monocytes expressing this receptor was also calculated from the FL1 histogram. A marker was set on the subpopulation of monocytes with increased Fc yRIII expression, against a background control, and the percentage of cells within the marked region was then calculated with the 'Histats' in the LYSIS programme. The percentage of monocytes with increased expression of FcyRIII was calculated for each of the patient samples, but on a smaller number of controls (n = 15) than originally tested.
Statistical analysis
Mean MFI values for the three receptors, on both neutrophils and monocytes, were calculated for each of the patient groups and the controls. MFI values for the patient groups and the controls were also compared by analysis of variance (ANOVA) and a modified t test for unpaired samples, based on a pooled estimate of variance. A p value <0.05 was taken to be significant. Similiar calculations, including patient group mean valuesand t test comparisons, were performed on the percentage of monocytes with increased expression of Fc yRIII.
Results
Examination of MFI values indicated that whilst Fc yR expression was increased in patients with either systemic or localised infection, there was little difference in expression between the non-infected patients and the controls (Table 1) . There was no significant difference in the level of expression of FcyRI, FcyRII or FcyRIII in patients with either systemic or localised infection. However, for Fc yRI expression, there was a significant difference between patients with either systemic or localised infection, compared to the controls, for both neutrophils (p < 0.0001, p = 0.0005) (Fig. 1A) and monocytes (p < 0.0001, p = 0.001) (Fig. 1B) . FcyRI expression was also significantly increased in the two infected patient groups compared to patients without evidence of infection, for neutrophils (p = 0.02, p = 0.04) (Fig.  1A) . The monocytic expression of FcyRIII was also significantly increased in patients with either systemic or localised infection compared to controls (p < 0.0001, p < 0.0001). This increased expression of FcyRIII in infection was more apparent when comparisons were made by calculations involving the percentage of monocytes expressing increased levels of this receptor. In this case the percentage of monocytes showing a higher level of FcyRIII expression was significantly increased in both infected groups compared not only to the controls (p =0.009, p = 0.003), but also to patients without evidence of infection (p = 0.009, p = 0.006) (Fig. 1C) . Analysis of the MFI values obtained in patients with systemic infection also indicated that some bacterial isolates induced a higher FcyR response than others. For FcyRI, on both neutrophils and monocytes, gramnegative bacilli appeared to elicit a higher receptor response than either streptococci or staphylococci ( Fig.  2A) . Similarly, for FcyRIII, the percentage of monocytes with increased expression of this receptor, showed a notable increase in infections caused by gram-negative bacilli (Fig. 2B ). In turn, for both FcyRI and FcyRIII, Streptococcus spp. such as S.
pneumoniae, induced a higher FcyR response than most of the staphylococcal isolates. The gram-negative organisms involved in localised infections also induced a high FcyR response, but at a lower level than the gram-negative organisms causing systemic infection.
Discussion
It is now recognised that the high mortality rate associated with systemic infection arises not only from the presence and establishment of organisms in the bloodstream, but also from the body's own immune response to the infection, a response that can trigger a potentially fatal cascade of inflammatory mediators [I, 1 1, 121. Terms such as sepsis, sepsis syndrome and septic shock are no longer used to denote separate infectious disorders. These terms are now used to represent increasingly severe stages of the same infectious process, the progress of which relates to the severity of the systemic response rather than to the infection itself [ 131. In a recent study involving HIV-infected patients, the expression of FcyRI and the percentage of monocytes expressing FcyRIII were also found to be significantly increased, compared to controls [19]. In a further study involving HIV-infected patients, the level of expression of FcyRI and the percentage of monocytes expressing FcyRIII were not only found to be significantly increased, but were also found to have an association with serious or opportunist infections in these patients (unpublished observations).
The results of the present study also indicate that a similar increase in FcyR expression occurred in Increased FcyR expression is thought to result from the release of IFN-y from activated T cells after antigenic challenge [8, 9] . Therefore, during infection, the level of FcyR expression will. depend on the ability of the organism to induce IFN-y release. In the case of gram-negative bacilli, bacterial LPS interacts with LPS-binding protein, through the CD14 glycoprotein, to bring about release of proinflammatory cytokines with subsequent T-cell activation [ 131. However, recent studies have indicated that LPS can act directly on natural killer cells, to produce an additional source of . Taken together this could explain the high level of FcyR expression observed in gram-negative infection in this study.
In the case of infection caused by grampositive organisms such as streptococci, increased levels of IFN-y could result from the action of superantigens, e.g., exotoxins and certain M proteins. By circumventing the normal rules of antigen presentation and T-cell recognition, these antigens can stimulate large numbers of T lymphocytes and thus amplify the release of cytokines [21] . Studies of bacteria-induced Fc yR expression could further our understanding of the inflammatory response in infection.
The results of this preliminary study suggest that the measurement of FcyR expression could be used as an early indicator of infection. Quantification of the FcyR response might also help to indicate the type or severity of infection and even the organism involved. Furthermore, as the method of determination of FcyR is both rapid and simple to perform, this test could be used easily in conjunction with standard culture technique and could serve as a useful tool in the treatment of infection.
